We hypothesized that the decrease in PTEN was on account of the low expression of USP52, that is, USP52 inhibited the tumorigenesis of NSCLC by up-regulating the tumor suppressor of PTEN. This evidence concerns the gene PAN2 and non-small cell lung carcinoma.